NOVEL BIOLOGY
PATIENT IMPACT
Immunitas is committed to discovering and developing novel, differentiated therapeutics for patients with cancer and autoimmune diseases. Our lead program, IMT-009, targets CD161 and is in clinical trials for patients with refractory tumors across a variety of indications including MSS Colorectal Cancer, Head and Neck Cancer, and Non-Small Cell Lung Cancer. Our second program is a novel therapeutic for the treatment of autoimmune disease that builds on our specialized foundational knowledge of the CD161-CLEC2D pathway.
TEAM
We are committed to the growth and success of our employees. We look to bring on collaborative proactive team members. Please see below for active postings.
OUR BIOLOGY
Immunitas was founded by a team of highly renowned cancer research and therapeutic antibody pioneers from Dana Farber Cancer Institute, Mass General Cancer Center, the Broad Institute, and MIT. That team identified CD161 as a compelling T cell target for oncology. The company now has programs targeting the CD161-CLEC2D pathway across multiple oncology and autoimmune diseases.
PIPELINE
Immunitas is building a robust pipeline of highly differentiated immuno-oncology and autoimmune antibody-based therapeutics. We are advancing our wholly owned development candidate, IMT-009 (a-CD161 mAb), through clinical evaluation.
NEWS & EVENTS
November 16, 2021
JOIN US
Full-time Opportunities
Immunitas is hiring passionate leaders, scientists, and development specialists to join our team of high-performance employees that are excited by the pursuit of novel biology. Please contact us at info@immunitastx.com for more information.
In addition to a competitive benefits package including healthcare and paid time off, Immunitas also offers the following:
Company-wide shutdown between Christmas and New Years
4- week paid sabbatical after 4 years of employment
$5,000 tuition reimbursement for career development
Paid parental leave
Internship and Cooperative Programs
We are committed to providing meaningful, goal-oriented internship and co-op programs to both undergraduate and graduate students. We welcome applicants from the biology, computer and laboratory science disciplines, as well as from finance, marketing, and business development.
Many members of the Immunitas team, including our CEO, benefited from strong internship experiences and we are committed to providing a strong learning and growth experience. Interns are integrated with the team, have access to company leadership, and will gain valuable scientific and business experience.
Open Positions
Check back for new openings.
